Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
CROMSOURCE, an international contract research organization (CRO) providing services to the pharmaceutical, biotechnology, and medical device industries, has announced the appointment of four senior executives to its Management Team.
read more
Six CROs have introduced Align Clinical CRO, a new industry standards group dedicated to making it easier for sponsors and CROs to work together during clinical trials.
read more
Crown Bioscience, Inc., a wholly owned subsidiary of Crown Bioscience International, a global drug discovery and development solutions company providing translational platforms to advance oncology and metabolic disease research, has announced the ...
read more
Crown Bioscience and Medical & Biological Laboratories (MBL), JSR Life Sciences companies announced the formation of a joint venture, to further expand the provision of Crown Bioscience’s preclinical services to Japanese customers.
read more
Crown Bioscience and Medical & Biological Laboratories (MBL), JSR Life Sciences companies, announced the formation of a joint venture, to further expand the provision of Crown Bioscience’s preclinical services to Japanese customers.
read more
Crown Bioscience announced the extension of its partnership with NEXT Oncology. This partnership will continue to leverage Crown Bioscience's experience in developing clinically relevant cancer organoid and patient-derived xenograft (PDX) models, ...
read more
Crown Bioscience announced four new preclinical translational NASH models in development.
read more
Crown Bioscience announced the opening of a new facility in San Diego, CA.
read more
Crown Bioscience announces its results for the second quarter ending June 30, 2017.
read more
Thursday, November 16, 2017
Crown Bioscience has held an extraordinary general meeting and announced results of stockholder elections for the company’s 2017 Board of Directors.
read more
Crown Bioscience has expanded its oncology services with new models, cell lines and assays at its Center of Excellence for Oncology in San Diego.
read more
Tuesday, December 18, 2018
Crown Bioscience has recently announced the expansion of its existing translational oncology research capacity by opening a new site in Suzhou, Jiangsu, China.
read more
Crown Bioscience, Inc., a leading global drug discovery and development service company, today announces that it has entered into a strategic partnership with Shin Nippon Biomedical Laboratories, Ltd., a Japan-based company engaged in the provision ...
read more
Wednesday, December 16, 2015
Crown Bioscience, a global drug discovery and development services company that has the world’s largest collection of spontaneously diabetic translational models, has established an ultrasound diagnostic method by using its translational model for ...
read more
Thursday, December 03, 2015
Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, has significantly increased the capacity of its United Kingdom facilities.
read more